3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Burkitt Lymphoma
16
Precursor Cell Lymphoblastic Leukemia-Lymphoma
11
Leukemia, Biphenotypic, Acute
7
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
5
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
4
Leukemia, Myeloid, Acute
3
Leukemia, Myeloid, Accelerated Phase
3
Blast Crisis
3
Lymphoma, Mantle-Cell
2
Down Syndrome
2
Blastic Plasmacytoid Dendritic Cell Neoplasm
2
Renal Pelvis and Ureter Urothelial Carcinoma
1
Osteosarcoma
1
Oropharyngeal Neoplasms
1
Mouth Neoplasms
1
Leukemia, Myelomonocytic, Juvenile
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Laryngeal Neoplasms
1
Hypopharyngeal Neoplasms
1
Head and Neck Neoplasms
1
Carcinoma
1
Anemia, Refractory, with Excess of Blasts
1
Interventions
glofitamab
2
Cyclophosphamide
2
pembrolizumab
1
obinutuzumab
1
fludarabine phosphate
1
Whole-Body Irradiation
1
Tacrolimus
1
Sirolimus
1
Peripheral Blood Stem Cell Transplantation
1
Oxaliplatin
1
Mycophenolic Acid
1
Methotrexate
1
Melphalan
1
Gemcitabine
1
Etoposide
1
Cyclosporine
1
Busulfan
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Dendritic Cell Sarcoma, Interdigitating
×
merphos
×
90 days
×
Clear all
No trials found.